Jianfeng Group Lin2015 -001 (Announcement of Jianfeng Group on Progress of Naisikang)
Release time:
2020-08-05
Securities Abbreviations: Jianfeng Group Securities Code: 600668 Number: Pro 2015-001
Bond Abbreviations: 13 Spike 01 Bond Code: 122227
Bond Abbreviations: 13 Spike 02 Bond Code: 122344
Zhejiang Jianfeng Group Co., Ltd.
Progress Announcement on Jianfeng Pharmaceutical's Acquisition of Naisikang's Equity
The Board of Directors and all directors of the Company guarantee that there are no false records, misleading statements or major omissions in the contents of this announcement, and assume individual and joint responsibility for the truthfulness, accuracy and completeness of its contents.
2014 7 29 , the company once announced that Zhejiang Jianfeng pharmaceutical co., ltd., the controlling subsidiary of the company, signed the "framework agreement on equity transfer of Zhejiang nesikang pharmaceutical co., ltd." (hereinafter referred to as the "framework agreement") with Creative Medicine and Xi' an zizhitong investment co., ltd, it is proposed to transfer its 70% and 25% stake in Zhejiang Niskang Pharmaceutical Co., Ltd. For the above matters, please refer to the "Prompt Announcement of Zhejiang Jianfeng Group Co., Ltd. on Signing of Equity Transfer Framework Agreement by Subsidiaries" issued by the Company on , , , , , , , ,
.After the framework agreement was signed, according to the agreement, we hired audit, evaluation and other intermediary agencies with securities qualification to conduct a comprehensive audit, evaluation and due diligence on Zhejiang Nestkang Pharmaceutical Co., Ltd. , and conducted many consultations and negotiations with the equity transferor, however, due to the failure to solve the environmental protection problems of
Zhejiang Naisikang Pharmaceutical Co., Ltd., a consensus could not be reached.In view of the fact that the exclusive period stipulated in the Framework Agreement has expired, after friendly negotiation, all parties jointly decided to terminate the equity transfer of Nessikang Company. On April 13, 2015, parties
signed the Memorandum on Termination of the Framework Agreement on Equity Transfer of Zhejiang Nessikang Pharmaceutical Co., Ltd. The main contents of the memorandum are as follows:1. The parties agree to terminate the Framework Agreement on Equity Transfer of Zhejiang Nestkang Pharmaceutical Co., Ltd. signed on July 28, 2014.
2. Each party shall bear the expenses (audit and evaluation expenses) paid for the above-mentioned equity transfer, and shall not claim compensation or compensation from the other party.
3. Creative Medicine and Xi 'an Zizhitong Investment Co., Ltd. may seek a third party to contact, negotiate and negotiate the above-mentioned equity transfer of Zhejiang Naisikang Pharmaceutical Co., Ltd.
The termination of the equity transfer of Zhejiang Naisikang Pharmaceutical Co., Ltd.
will not have a material adverse impact on the production and operation of the Company.is hereby announced
Zhejiang Jianfeng Group Co., Ltd.
Board of Directors
More information
Representatives of the 20th Congress preached the 20th Congress at the peak.
On the afternoon of November 11, a special lecture on the spirit of the Party's 20th Congress was held in the conference room of the Peak Building. Yang Xiayun, a representative of the 20th National Congress, walked into the peak and preached his understanding of the spirit of the 20th National Congress for Party members through personal experience.
2022
11-23
The group party committee organizes and learns the twenty spirits.
On the afternoon of October 28, the party Committee of the group organized all members to hold a special study meeting to earnestly study and understand the communique of the first plenary session of the 20th central Committee of the communist party of China and the revision of the party constitution. Jiang Xiaomeng, Secretary of the Party committee of the group, stressed at the study meeting that the 20th National Congress of the Communist Party of China has drawn a grand blueprint for building a socialist modern country in an all-round way, opened a new chapter in the era of national development, and pointed out the direction for the future development of enterprises. Party organizations at all levels of the group should pay full attention to and earnestly implement it, actively organize party members and cadres to learn the spirit of the spirit of the 20th National Congress, And to guide the future work practice.
2022
11-01
Spike Party Members and Cadres Watch the Opening Meeting of the 20th Congress
At 10 a.m. on October 16, the 20th National Congress of the Communist Party of China was solemnly opened in the Great Hall of the People in Beijing. Xi Jinping delivered a report to the Party's 20th National Congress on behalf of the 19th Central Committee. The group company attaches great importance to and carefully deploys, and organizes all party members and management backbones of the group headquarters and subsidiaries to watch the live broadcast of the opening meeting through the Internet, TV and other methods.
2022
10-23
Jiang Xiaomeng was hired as the "Shuanglong Escort" entrepreneurial mentor.
On September 16, Jiang Xiaomeng, Secretary of the Party committee and chairman of the group company, was employed as the entrepreneurial mentor of "Shuanglong escort" at the launching ceremony of the special action of "Shuanglong escort steady progress and quality improvement" held in Jinhua City and the promotion meeting of innovative products of key talent enterprises in Jinhua City.
2022
09-27
From August 18th to 19th, the 12th Congress of the Zhejiang Federation of Industry and Commerce was held in Hangzhou, and the 12th leadership of the Provincial Federation of Industry and Commerce was elected. Jiang Xiaomeng, Secretary of the Party Committee and Chairman of the Group, was re-elected as Vice President of Zhejiang Chamber of Commerce.
2022
09-01